Chemed Financial Statements From 2010 to 2024
CHE Stock | USD 641.32 2.94 0.46% |
Gross Profit 765.1 M | Profit Margin 0.1203 | Market Capitalization 9.7 B | Enterprise Value Revenue 4.253 | Revenue 2.3 B |
Check Chemed Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemed main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.9 M, Interest Expense of 3.2 M or Selling General Administrative of 218.4 M, as well as many exotic indicators such as Short Term Coverage Ratios of 5.77, Price Earnings Ratio of 33.91 or Price To Sales Ratio of 4.08. Chemed financial statements analysis is a perfect complement when working with Chemed Corp Valuation or Volatility modules.
Chemed | Select Account or Indicator |
Chemed Corp Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemed Corp Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemed Corp Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Chemed Fundamental Market Drivers
Forward Price Earnings | 27.3973 | |
Cash And Short Term Investments | 264 M |
Chemed Upcoming Events
22nd of February 2024 Upcoming Quarterly Report | View | |
24th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
22nd of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
About Chemed Corp Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Chemed Corp income statement, its balance sheet, and the statement of cash flows. Chemed Corp investors use historical funamental indicators, such as Chemed Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Chemed Corp investors may use each financial statement separately, they are all related. The changes in Chemed Corp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemed Corp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chemed Corp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chemed Corp. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for 2024 | ||
Current Deferred Revenue | 6.9 M | 6.5 M | |
Total Revenue | 2.3 B | 2.4 B | |
Cost Of Revenue | 1.5 B | 1.6 B | |
Ebit Per Revenue | 0.15 | 0.16 |
Pair Trading with Chemed Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemed Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemed Corp will appreciate offsetting losses from the drop in the long position's value.Moving together with Chemed Stock
0.61 | RNLX | Renalytix AI Report 4th of April 2024 | PairCorr |
Moving against Chemed Stock
0.92 | KA | Kineta Inc Report 29th of March 2024 | PairCorr |
0.87 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.81 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.68 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
0.67 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
The ability to find closely correlated positions to Chemed Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemed Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemed Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemed Corp to buy it.
The correlation of Chemed Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemed Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemed Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemed Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Chemed Corp Correlation against competitors. For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.Note that the Chemed Corp information on this page should be used as a complementary analysis to other Chemed Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Chemed Stock analysis
When running Chemed Corp's price analysis, check to measure Chemed Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemed Corp is operating at the current time. Most of Chemed Corp's value examination focuses on studying past and present price action to predict the probability of Chemed Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemed Corp's price. Additionally, you may evaluate how the addition of Chemed Corp to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Chemed Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.432 | Dividend Share 1.56 | Earnings Share 17.91 | Revenue Per Share 150.46 | Quarterly Revenue Growth 0.072 |
The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.